# An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke

> **NCT04952064** · PHASE4 · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 300 (actual)

## Conditions studied

- Stroke, Ischemic

## Interventions

- **DRUG:** Monosialoganglioside GM1

## Key facts

- **NCT ID:** NCT04952064
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-28
- **Primary completion:** 2022-07-18
- **Final completion:** 2022-07-18
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2022-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04952064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04952064, "An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04952064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*